The pathophysiology and management of vascular calcification in chronic kidney disease patients

References

• Palit S, Kendrick J. Vascular calcification in chronic kidney disease: role of disordered mineral metabolism. Curr Pharm Des. 2014;20(37):5829–5833.
   PubMed Web of Science ®Google Scholar
• Kaur R, Singh R. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications. Life Sci. 2022 Dec 15;311(Pt B):121148.
   PubMedGoogle Scholar
• Hutcheson JD, Blaser MC, Aikawa E. Giving calcification its due: recognition of a diverse disease: a first attempt to standardize the field. Circ Res. 2017 Jan 20;120(2):270–273.
   PubMed Web of Science ®Google Scholar
• Gross ML, Meyer HP, Ziebart H, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007 Jan;2(1):121–134.
   PubMed Web of Science ®Google Scholar
• Fakhry M, Skafi N, Fayyad-Kazan M, et al. Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification. J Cell Physiol. 2018 May;233(5):4056–4067.
   PubMed Web of Science ®Google Scholar
• Durham AL, Speer MY, Scatena M, et al. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018 Mar 15;114(4):590–600.
   PubMed Web of Science ®Google Scholar
• Dai L, Schurgers LJ, Shiels PG, et al. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol Dial Transplant. 2020 Mar 1;35(Suppl 2):ii31–ii37.
   PubMedGoogle Scholar
• Voelkl J, Cejka D, Alesutan I. An overview of the mechanisms in vascular calcification during chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 Jul;28(4):289–296.
   PubMed Web of Science ®Google Scholar
• Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000 Sep 29;87(7):E10–7.
   PubMed Web of Science ®Google Scholar
• Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004 Nov;15(11):2857–2867.
   PubMed Web of Science ®Google Scholar
• Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011 Sep 2;109(6):697–711.
   PubMed Web of Science ®Google Scholar
• Hou Y-C, Liu W-C, Zheng C-M, et al. Role of vitamin D in uremic vascular calcification. BioMed research international. 2017;2017:2803579. DOI:10.1155/2017/2803579.
   PubMed Web of Science ®Google Scholar
• Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010 Jan;5(Suppl 1):S23–30.
   PubMed Web of Science ®Google Scholar
• Montezano AC, Zimmerman D, Yusuf H, et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010 Sep;56(3):453–462.
   PubMed Web of Science ®Google Scholar
• Kircelli F, Peter ME, Sevinc OE, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012 Feb;27(2):514–521.
   PubMed Web of Science ®Google Scholar
• Molnar AO, Biyani M, Hammond I, et al. Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study. BMC Nephrol. 2017 Apr 6;18(1):129.
   PubMedGoogle Scholar
• Ishimura E, Okuno S, Kitatani K, et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol. 2007 Oct;68(4):222–227.
   PubMed Web of Science ®Google Scholar
• Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011 Jan;22(1):124–136.
   PubMed Web of Science ®Google Scholar
• Shalhoub V, Shatzen EM, Ward SC, et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest. 2012 Jul;122(7):2543–2553
   PubMed Web of Science ®Google Scholar
• Hené RJ, Boer P, Koomans HA, et al. Plasma aldosterone concentrations in chronic renal disease. Kidney Int. 1982 Jan;21(1):98–101.
   PubMed Web of Science ®Google Scholar
• Fischer SS, Kempe DS, Leibrock CB, et al. Hyperaldosteronism in Klotho-deficient mice. Am J Physiol Renal Physiol. 2010 Nov;299(5):F1171–7.
   PubMed Web of Science ®Google Scholar
• Voelkl J, Alesutan I, Leibrock CB, et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest. 2013 Feb;123(2):812–822.
   PubMed Web of Science ®Google Scholar
• Viegas CS, Rafael MS, Enriquez JL, et al. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):399–408.
   PubMed Web of Science ®Google Scholar
• Viegas CSB, Costa RM, Santos L, et al. Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: implications for calcification-related chronic inflammatory diseases. PLoS One. 2017;12(5):e0177829.
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Schurgers LJ, Uiterwijk HH, et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 2012 Sep;82(5):605–610.
   PubMed Web of Science ®Google Scholar
• Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997 Mar 6;386(6620):78–81.
   PubMed Web of Science ®Google Scholar
• Willems BA, Furmanik M, Caron MMJ, et al. UCMA/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling. Sci Rep. 2018 Mar 21;8(1):4961.
   PubMedGoogle Scholar
• Roumeliotis S, Dounousi E, Eleftheriadis T, et al. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. Int J Mol Sci. 2019;20(3):628. DOI:10.3390/ijms20030628.
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Koos R, Schurgers LJ, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost. 2010 Oct;104(4):811–822.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Cranenburg EC, Matrix Gla-protein: VC. the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008 Oct;100(4):593–603.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Barreto DV, Barreto FC, et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010 Apr;5(4):568–575.
   PubMed Web of Science ®Google Scholar
• Delanaye P, Krzesinski JM, Warling X, et al. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol. 2014 Sep;4(15):145.
   Google Scholar
• Roumeliotis S, Roumeliotis A, Stamou A, et al. The Association of dp-ucMGP with Cardiovascular Morbidity and Decreased Renal Function in Diabetic Chronic Kidney Disease. Int J Mol Sci. 2020 Aug 21;21(17):6035. DOI:10.3390/ijms21176035.
   PubMed Web of Science ®Google Scholar
• Nigwekar SU, Bloch DB, Nazarian RM, et al. Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. J Am Soc Nephrol. 2017 Jun;28(6):1717–1722.
   PubMed Web of Science ®Google Scholar
• Suttie JW. The biochemical basis of warfarin therapy. Adv Exp Med Biol. 1987;214:3–16.
   PubMedGoogle Scholar
• Nigwekar SU, Zhao S, Wenger J, et al. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. J Am Soc Nephrol. 2016 Nov;27(11):3421–3429.
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol. 2011 Mar-Apr;24(2):142–148.
   PubMed Web of Science ®Google Scholar
• Roumeliotis S, Duni A, Vaios V, et al. Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: are We There Yet? Nutrients. 2022 Feb 22;14:5.
   Web of Science ®Google Scholar
• Witham MD, Lees JS, White M, et al. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: the K4Kidneys Randomized Controlled Trial. J Am Soc Nephrol. 2020 Oct;31(10):2434–2445.
   PubMed Web of Science ®Google Scholar
• Holden RM, Booth SL, Zimmerman D, et al. Inhibit progression of coronary artery calcification with vitamin k in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-centre, pilot trial. Nephrol Dial Transplant. 2022 May 31.
   Google Scholar
• Saritas T, Reinartz S, Krüger T, et al. Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial. Clin Kidney J. 2022;15(12):2300–2311.
   Web of Science ®Google Scholar
• Kim JS, Hwang HS. Vascular Calcification in Chronic Kidney Disease: distinct Features of Pathogenesis and Clinical Implication. Korean Circ J. 2021 Dec;51(12):961–982.
   PubMed Web of Science ®Google Scholar
• Leopold JA. Vascular calcification: an age-old problem of old age. Circulation. 2013 Jun 18;127(24):2380–2382.
   PubMed Web of Science ®Google Scholar
• Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008 Jun 3;117(22):2938–2948.
   PubMed Web of Science ®Google Scholar
• Chen J, Budoff MJ, Reilly MP, et al. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA Cardiol. 2017 Jun 1;2(6):635–643.
   PubMed Web of Science ®Google Scholar
• Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000 May 18;342(20):1478–1483.
   PubMed Web of Science ®Google Scholar
• Fang Y, Ginsberg C, Sugatani T, et al. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int. 2014 Jan;85(1):142–150.
   PubMed Web of Science ®Google Scholar
• Disthabanchong S, Boongird S. Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease. World J Nephrol. 2017 May 6;6(3):100–110.
   PubMedGoogle Scholar
• Stompor T, Rajzer M, Pasowicz M, et al. Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int J Artif Organs. 2006 Aug;29(8):736–744.
   PubMed Web of Science ®Google Scholar
• Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004 Mar;43(3):572–579.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Akishita M, Yu W, et al. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis. 2004 Mar;173(1):13–18.
   PubMed Web of Science ®Google Scholar
• van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke. 2001 Feb;32(2):454–460.
   PubMed Web of Science ®Google Scholar
• Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults. Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1674–1679.
   PubMed Web of Science ®Google Scholar
• Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997 Jul 25;132(2):245–250.
   PubMed Web of Science ®Google Scholar
• Wilson PWF, Kauppila LI, O’Donnell CJ, et al. Abdominal Aortic Calcific Deposits Are an Important Predictor of Vascular Morbidity and Mortality. Circulation. 2001;103(11):1529–1534.
   PubMed Web of Science ®Google Scholar
• Walsh CR, Cupples LA, Levy D, et al. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study. Am Heart J. 2002 Oct;144(4):733–739.
   PubMed Web of Science ®Google Scholar
• Raggi P, Bellasi A, Ferramosca E, et al. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int. 2007 Apr;71(8):802–807.
   PubMed Web of Science ®Google Scholar
• Bellasi A, Ferramosca E, Muntner P, et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006 Nov;70(9):1623–1628.
   PubMed Web of Science ®Google Scholar
• Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007 Mar;49(3):417–425.
   PubMed Web of Science ®Google Scholar
• Verbeke F, Van Biesen W, Honkanen E, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011 Jan;6(1):153–159.
   PubMed Web of Science ®Google Scholar
• Hwang HS, Lim SW, Sun IO, et al. Clinical significance of preexisting microcalcification in the iliac artery in renal transplant recipients. Transplantation. 2015 Apr;99(4):811–817.
   PubMed Web of Science ®Google Scholar
• Bellasi A, Raggi P. Techniques and technologies to assess vascular calcification. Semin Dial. 2007 Mar-Apr;20(2):129–133.
   PubMed Web of Science ®Google Scholar
• Guérin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000 Jul;15(7):1014–1021.
   PubMed Web of Science ®Google Scholar
• Oh DJ. Continuous ambulatory peritoneal dialysis patients show high prevalence of carotid artery calcification which is associated with a higher left ventricular mass index. J Korean Med Sci. 2005 Oct;20(5):848–852.
   PubMed Web of Science ®Google Scholar
• Sumida Y, Nakayama M, Nagata M, et al. Carotid artery calcification and atherosclerosis at the initiation of hemodialysis in patients with end-stage renal disease. Clin Nephrol. 2010 May;73(5):360–369.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Ura Y, Nagata M, et al. Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study. BMC Nephrol. 2011 Oct;15(12):56.
   Google Scholar
• Liviakis L, Pogue B, Paramsothy P, et al. Carotid intima-media thickness for the practicing lipidologist. J Clin Lipidol. 2010 Jan-Feb;4(1):24–35.
   PubMed Web of Science ®Google Scholar
• O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999 Jan 7;340(1):14–22.
   PubMed Web of Science ®Google Scholar
• Roumeliotis A, Roumeliotis S, Panagoutsos S, et al. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease. Ren Fail. 2019 Nov;41(1):131–138.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007 Jan 30;115(4):459–467.
   PubMed Web of Science ®Google Scholar
• Benedetto FA, Mallamaci F, Tripepi G, et al. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001 Nov;12(11):2458–2464.
   PubMed Web of Science ®Google Scholar
• Shoji T, Kawagishi T, Emoto M, et al. Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis. 2000 Nov;153(1):257–258.
   PubMed Web of Science ®Google Scholar
• Poli A, Tremoli E, Colombo A, et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 1988 Apr;70(3):253–261.
   PubMed Web of Science ®Google Scholar
• Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014 Oct;7(10):1025–1038.
   PubMed Web of Science ®Google Scholar
• Disthabanchong S. Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol. 2012 Apr 6;1(2):43–53.
   PubMedGoogle Scholar
• Lima A, Carrilho P, Germano A. Clinical and ultrasound evaluation for hemodialysis access creation. Nefrologia (Engl Ed). 2021.
   Google Scholar
• Shenoy S, Darcy M. Ultrasound as a tool for preoperative planning, monitoring, and interventions in dialysis arteriovenous access. AJR Am J Roentgenol. 2013 Oct;201(4):W539–43.
   PubMed Web of Science ®Google Scholar
• Karohl C, D’Marco Gascón L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol. 2011 Aug 23;7(10):567–577.
   PubMed Web of Science ®Google Scholar
• Lembcke A, Hein PA, Dohmen PM, et al. Pictorial review: electron beam computed tomography and multislice spiral computed tomography for cardiac imaging. Eur J Radiol. 2006 Mar;57(3):356–367.
   PubMed Web of Science ®Google Scholar
• Dube P, DeRiso A, Patel M, et al. Vascular Calcification in Chronic Kidney Disease: diversity in the Vessel Wall. Biomedicines. 2021 Apr 8;9(4): 404.
   PubMed Web of Science ®Google Scholar
• Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990 Mar 15;15(4):827–832.
   PubMed Web of Science ®Google Scholar
• The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37(2–4):1–332.
   Google Scholar
• De Mauri A, Brambilla M, Chiarinotti D, et al. Estimated radiation exposure from medical imaging in hemodialysis patients. J Am Soc Nephrol. 2011 Mar;22(3):571–578.
   PubMed Web of Science ®Google Scholar
• Marinelli A, Pistolesi V, Pasquale L, et al. Diagnosis of Arterial Media Calcification in Chronic Kidney Disease. Cardiorenal Med. 2013 Jul;3(2):89–95.
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Budoff M, Hokanson JE, et al. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int. 2005 Sep;68(3):1258–1266.
   PubMed Web of Science ®Google Scholar
• Poli FE, Gulsin GS, McCann GP, et al. The assessment of coronary artery disease in patients with end-stage renal disease. Clin Kidney J. 2019 Oct;12(5):721–734.
   PubMed Web of Science ®Google Scholar
• KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2017 Jul 7;7(1):1–59.
   Web of Science ®Google Scholar
• Scialla JJ, Kao WH, Crainiceanu C, et al. Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr;9(4):745–755.
   PubMed Web of Science ®Google Scholar
• Bozic M, Méndez-Barbero N, Gutiérrez-Muñoz C, et al. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease. Atherosclerosis. 2018;270:13–20.
   PubMed Web of Science ®Google Scholar
• Turan MN, Kircelli F, Yaprak M, et al. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients. Int Urol Nephrol. 2016 Apr;48(4):609–617.
   PubMed Web of Science ®Google Scholar
• Cai H, Zhu X, Lu J, et al. A Decreased Level of Soluble Klotho Can Predict Cardiovascular Death in No or Mild Abdominal Aortic Calcification Hemodialysis Patients. Front Med (Lausanne). 2021;8:672000.
   PubMed Web of Science ®Google Scholar
• Lv W, Guan L, Zhang Y, et al. Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4. Int Urol Nephrol. 2016 Dec;48(12):2043–2050.
   PubMed Web of Science ®Google Scholar
• Yan J, Li L, Zhang M, et al. Circulating bone-specific alkaline phosphatase and abdominal aortic calcification in maintenance hemodialysis patients. Biomark Med. 2018 Nov;12(11):1231–1239.
   PubMed Web of Science ®Google Scholar
• Kim DW, Hwang SY, Nam YJ, et al. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease. Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1476–1483.
   PubMed Web of Science ®Google Scholar
• Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A Formation of colloidal calciprotein particles. J Biol Chem. 2003 Apr 11;278(15):13333–13341.
   PubMed Web of Science ®Google Scholar
• Koppert S, Buscher A, Babler A, et al. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity. Front Immunol. 2018;9:1991.
   PubMed Web of Science ®Google Scholar
• Viegas CSB, Santos L, Macedo AL, et al. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification. Arterioscler Thromb Vasc Biol. 2018;38(3):575–587.
   PubMed Web of Science ®Google Scholar
• Silaghi CN, Ilyes T, Van Ballegooijen AJ. Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease. J Clin Med. 2020;9(5):1287.
   PubMed Web of Science ®Google Scholar
• Pasch A, Farese S, Graber S, et al. Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol. 2012 Oct;23(10):1744–1752.
   PubMed Web of Science ®Google Scholar
• Wu R, Zhou S, Liu M, et al. Clinical Significance of miR-21-5p in Predicting Occurrence and Progression of Uremic Vascular Calcification in Patients with End-Stage Renal Disease. Yonsei Med J. 2022 Mar;63(3):252–258.
   PubMed Web of Science ®Google Scholar
• Chao C-T, Yeh H-Y, Tsai Y-T, et al. A combined microRNA and target protein-based panel for predicting the probability and severity of uraemic vascular calcification: a translational study. Cardiovasc Res. 2021 Jul 7;117(8):1958–1973.
   PubMed Web of Science ®Google Scholar
• Lanzer P, Hannan FM, Lanzer JD, et al. Medial Arterial Calcification: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 [2021 sep 14];78(11):1145–1165.
   PubMed Web of Science ®Google Scholar
• Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension. 2006 Jun;47(6):1027–1034.
   PubMed Web of Science ®Google Scholar
• Nigwekar SU, Brunelli SM, Meade D, et al. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol. 2013 Jul;8(7):1162–1170.
   PubMed Web of Science ®Google Scholar
• Nitta K, Ogawa T. Vascular calcification in end-stage renal disease patients. Contrib Nephrol. 2015;185:156–167.
   PubMed Web of Science ®Google Scholar
• Kranenburg G, de Jong PA, Bartstra JW, et al. Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum. J Am Coll Cardiol. 2018 Mar 13;71(10):1117–1126.
   PubMed Web of Science ®Google Scholar
• Helas S, Goettsch C, Schoppet M, et al. Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol. 2009 Aug;175(2):473–478.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Suzuki M, Hanafusa N, et al. Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis. Kidney Int Rep. 2021 Mar;6(3):605–612.
   PubMed Web of Science ®Google Scholar
• Shao JS, Cheng SL, Charlton-Kachigian N, et al. Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem. 2003 Dec 12;278(50):50195–50202.
   PubMed Web of Science ®Google Scholar
• Jamal SA, Vandermeer B, Raggi P, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013 Oct 12;382(9900):1268–1277.
   PubMed Web of Science ®Google Scholar
• Jung S, Querfeld U, Müller D, et al. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats. J Hypertens. 2012 Nov;30(11):2182–2191.
   PubMed Web of Science ®Google Scholar
• Lau WL, Leaf EM, Hu MC, et al. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int. 2012 Dec;82(12):1261–1270.
   PubMed Web of Science ®Google Scholar
• Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011 Apr;26(4):1327–1339.
   PubMed Web of Science ®Google Scholar
• Jaffe IZ, Tintut Y, Newfell BG, et al. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):799–805.
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Hamano T, Obi Y, et al. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD. J Am Soc Nephrol. 2019 Jun;30(6):1073–1085.
   PubMed Web of Science ®Google Scholar
• Xu C, Smith ER, Tiong MK, et al. Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: a Systematic Review of Clinical Trials. J Am Soc Nephrol. 2022 May;33(5):1011–1032.
   PubMed Web of Science ®Google Scholar